Molecular Studies and Clinical Correlations in Human Prostatic Disease

Running, not enrolling

Conditions studied: Prostate Cancer

In brief

The Genitourinary Oncology/Urology Services at Memorial Sloan-Kettering Cancer Center (MSKCC) participates in research for the control, treatment, and cure of cancer. The purpose of this study is to collect normal and cancerous tissues, in addition to blood, and other body fluid samples from men with prostate cancer or prostatic disease. These samples may be stored for future use or used immediately by researchers who study prostate cancer and try to find better ways to diagnose, prevent, and treat it. We will look for genetic changes and protein markers on these cells. We hope to learn more about what makes some people get prostate cancer, why some cancers are more aggressive than others, and why some cancers respond to or resist different treatments. We may also try to grow the tumor cells in the lab. We may find a new treatment for prostate cancer based on this research.

Key facts

Study ID

NCT00578240

Run by

Memorial Sloan Kettering Cancer Center

People needed

5290

Starts

1990-04-01

Expected to finish

2026-12-01

Last updated by the study team

2026-03-09

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men with prostate conditions representing the following disease states:
• No Cancer Diagnosis
• Clinically Localized Disease
• Rising PSA
• Clinical Metastases: Noncastrate
• Clinical Metastases: Castrate (Testosterone ≤ 50 ng/ml)
• Signed informed consent

You may not qualify if…

• Patients without any prostate related problems.

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.